Medicare -

MMWR Booster for: COVID-19 Cases and Hospitalizations Among Medicare Beneficiaries With and Without Disabilities — United States, January 1, 2020–November 20, 2021 / Weekly / June 17, 2022 / 71(24);791–796

Posted on April 6, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Higher Hospitalization Rates in Disability-Eligible Medicare Beneficiaries: COVID-19-associated hospitalization rates were about 50% higher in disability-eligible beneficiaries compared to those eligible due to age, with rates increasing

MMWR Booster for: Topical Antifungal Prescribing for Medicare Part D Beneficiaries — United States, 2021, Weekly / January 11, 2024 / 73(1);1–5

Posted on January 19, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways High Volume of Prescriptions: In 2021, 6.5 million topical antifungal prescriptions, costing $231 million, were filled for Medicare Part D beneficiaries, equating to approximately one prescription for

Epidemiology, Broadly Speaking

Tag: Medicare